That's crazy. Have you looked at the price of overly

New Post Public Reply Private Reply Replies (0) Message Board
redspeed swordman #935
314
That's crazy. Have you looked at the price of overly expensive cantaloupe these days? Who could afford that? The grocery stores are trying to take advantage of DIYers that want to make their own penicillin.

Wouldn't it be 'cheaper' to not clean your shower, let the mold build up and scrape it off the grout? Is all mold the same? You'd save money that way.

I hope it works out for penelope pitstop as she sure has a lot of people cranked up on her 'experiment'

Makes ONE cup of tea with 1 1/2 teaspoons of gromwell root powder (not extract) and drinking that SAME cup a tea in 4 portions 4 times a day and taking a lecithin capsule with each portion.

Sure, that's just like the 'active ingredient' used in a certain extremely expensive supplement

You know, the company that is making 'dramatic claims'...

Tollovid is currently not approved to diagnose, treat, prevent or cure any disease, including COVID or Long COVID.

Brain fog in people with LC must be real as apparently they forget that Todos is saying the opposite and forget Tollovid is an extract of certain parts of certain gromwell roots and not ground up root. Oh and removes certain parts too.

Thinking about the outcomes...

1.) It doesn't work
2.) Helps a bit
3.) Helps a lot
4.) Total cure

With #1 and #2, do you double down with TWO cups of tea a day? That is going to cut your 21 day supply in 1/2. If that dozen work, do you keep doubling the tea cups?

#4 would be great, but I doubt anything would work 100% in LC people including paxlovid & tollovid as it's not been clearly defined what that is and other issues are woven in.

Well, let's see where this randomized study of 1 goes and keep and open mind.

BTW, you can buy GW seeds online for $4 plus shipping. Split it with 30 friends and it's cheaper.

https://strictlymedicinalseeds.com/product/gr...s-organic/

Todos Med Ltd. (TOMDF) Stock Research Links

TOMDF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 14

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 14

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 8

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 9

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 10

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Munters Group AB Sees Growth Amid Market Challenges

Updated Category News Views 174

Munters Group AB Performance Overview Munters Group AB recently reported a strong order intake and notable growth in net sales, presenting a positive outlook despite the challenges in the market. The company has been making significant strides in the first quarter of 2025, focusing on its commitment to operational excellence and strategic advancements across its business...

Continue Reading
Fold Holdings Set to Share Third Quarter Financial Results

Updated Category News Views 122

Fold Holdings Announces Earnings Call for Q3 2025 PHOENIX — Fold Holdings, Inc. (NASDAQ: FLD), a trailblazer in bitcoin financial services, has announced its upcoming earnings conference call for the third quarter of the fiscal year. This event is scheduled for Monday, November 10, 2025, at 5:00 PM Eastern Time. Investors and stakeholders are eagerly anticipating...

Continue Reading
Anticipating Earnings: What’s in Store for Wipro (WIT)?

Updated Category News Views 152

Upcoming Earnings Report for Wipro Wipro (NYSE: WIT) is approaching its quarterly earnings report, and investors are eager to see the results. Analysts are projecting an earnings per share (EPS) of $0.03. This figure is pivotal as it provides insights into the company’s financial health and operational efficiency. Guidance Matters More than Earnings While an earnings...

Continue Reading
Inertial Navigation Systems Market to Reach $21.63 Billion

Updated Category News Views 87

The Expanding Market for Inertial Navigation Systems With the rapid evolution of technology, the demand for advanced inertial navigation systems (INS) has significantly increased. According to projections from Brainy Insights, the market, which was valued at around USD 11 billion in 2023, is expected to grow to USD 21.63 billion by 2033. This impressive growth highlights...

Continue Reading
Remarkable Journey of Conjoined Twin Boys at CHOP Hospital

Updated Category News Views 287

Remarkable Journey of Conjoined Twin Boys at CHOP Hospital Amari and Javar Ruffin, who were born conjoined, are an inspiring example of medical advancement. This case represents Children's Hospital of Philadelphia's 32nd success in separating conjoined twins. Separation Process and Surgical Team After nearly a year at Children's Hospital of Philadelphia (CHOP), Amari and...

Continue Reading